Phase II clinical trial of OKT3 for acute graft-versus-host disease (GVHD) prophylaxis in allogeneic bone marrow transplantation (alloBMT).

被引：0
|
作者：
Alam, A [1 ]
Baer, MR [1 ]
Bernstein, S [1 ]
Bernstein, Z [1 ]
Christiansen, N [1 ]
Czuczman, M [1 ]
Schriber, J [1 ]
Slack, J [1 ]
Tezcan, H [1 ]
Wetzler, M [1 ]
Cooper, M [1 ]
Milk, B [1 ]
Ford, L [1 ]
Herzig, G [1 ]
McCarthy, P [1 ]
机构：
[1] ROSWELL PK CANC INST,BUFFALO,NY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：449 / 449
页数：1
相关论文
共 50 条
  • [21] Mycophenolate mofetil as acute graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation in a murine model.
    Huang, H
    Zheng, WY
    Lin, MF
    Fu, JY
    Zhang, RH
    BLOOD, 2001, 98 (11) : 325B - 325B
  • [22] COMBINATION OF CYCLOSPORINE AND METHOTREXATE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA
    MRSIC, M
    LABAR, B
    BOGDANIC, V
    NEMET, D
    PAVLETIC, Z
    PLAVSIC, F
    DOBRIC, I
    MARUSIC, M
    FRANCETIC, I
    KASTELAN, A
    KALENIC, S
    VRTAR, M
    MARKULINGRGIC, L
    AURER, I
    BONE MARROW TRANSPLANTATION, 1990, 6 (02) : 137 - 141
  • [23] Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis
    Paquette, RL
    Tran, L
    Landaw, EM
    BONE MARROW TRANSPLANTATION, 1998, 22 (04) : 351 - 357
  • [24] Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis
    RL Paquette
    L Tran
    EM Landaw
    Bone Marrow Transplantation, 1998, 22 : 351 - 357
  • [25] Hypereosinophilia as a presenting sign of acute graft-versus-host disease after allogeneic bone marrow transplantation
    McNeel, D
    Rubio, MT
    Damaj, G
    Emile, JF
    Belanger, C
    Varet, B
    Brousse, N
    Hermine, O
    Buzyn, A
    TRANSPLANTATION, 2002, 74 (12) : 1797 - 1800
  • [26] Donor lymphocyte infusions (DLI) after allogeneic blood and marrow transplantation (AlloBMT): Factors influencing graft-versus-host disease (GVHD) and response.
    Huff, CA
    Fuchs, EJ
    Vogelsang, GB
    Jones, RJ
    BLOOD, 2001, 98 (11) : 367B - 367B
  • [27] Unexplained effusions: Association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease
    Pretnar, J
    Cernelc, P
    Mlakar, U
    Fortuna, M
    BONE MARROW TRANSPLANTATION, 1996, 18 (04) : 826 - 826
  • [28] Prognostic effect on graft-versus-host disease(GVHD) from allogeneic bone marrow transplantation by ursodeoxycholic acid.
    Iwata, N
    Kuroiwa, T
    Kataoka, Y
    Nakata, A
    Seto, Y
    Saheki, K
    Takemoto, Y
    Kakishita, E
    HEPATOLOGY, 1999, 30 (04) : 326A - 326A
  • [29] PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING UNRELATED DONOR BONE-MARROW TRANSPLANTATION
    PHILLIPS, GL
    NEVILL, TJ
    SPINELLI, JJ
    NANTEL, SH
    KLINGEMANN, HG
    BARNETT, MJ
    SHEPHERD, JD
    CHAN, KW
    MEHARCHAND, JM
    SUTHERLAND, HJ
    REECE, DE
    MESSNER, HA
    BONE MARROW TRANSPLANTATION, 1995, 15 (02) : 213 - 219
  • [30] Unexplained effusions: Association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease
    Seber, A
    Khan, SP
    Kersey, JH
    BONE MARROW TRANSPLANTATION, 1996, 17 (02) : 207 - 211
12345